Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB13217ExperimentalSmall molecule
Fentiazac: Overview.
- Mechanism
- Curator reviewed
Pharmacologically active on Human Cyclooxygenases
- Formula / weight
- C17H12ClNO2S · 329.8 g/mol (avg)
- Code names
- BR 700 · WY-21,894
Resolves to
Clinical / RWD
Structure
InChIKey
JIEKMACRVQTPRC-UHFFFAOYSA-NSMILESOC(=O)CC1=C(N=C(S1)C1=CC=CC=C1)C1=CC=C(Cl)C=C1What you can answer from here — as of July 07, 2026
1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
Which companies are running trials of Fentiazac, in which indications and phases, and which of those programs are still active?